Compound details
3\'\'-O-Caffeoylcosmosiin
| Compound ID | CDAMM01307 |
|---|---|
| Common name | 3\'\'-O-Caffeoylcosmosiin | IUPAC name | [3,5-dihydroxy-2-[5-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-6-(hydroxymethyl)oxan-4-yl] 3-(3,4-dihydroxyphenyl)prop-2-enoate |
| Molecular formula | C30H26O13 |
| Retention time | 19.5 |
|---|---|
| Adduct | [M+Na]+ |
| Actual mz | 617.127 | Theoretical mz | 617.126 |
| Error | 1.92 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.9547 |
| Inchi key | GKSHQQDCYIESFY-KRXBUXKQNA-N |
|---|---|
| Smiles | O=C(OC1C(O)C(OC2=CC(O)=C3C(=O)C=C(OC3=C2)C=4C=CC(O)=CC4)OC(CO)C1O)C=CC5=CC=C(O)C(O)=C5 |
| Superclass | Phenylpropanoids and polyketides |
| Class | Flavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SEA |
| P02766 | TTR | Transthyretin | T86462 | SEA |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SEA |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SEA |
| P15121 | AKR1B1 | Aldose reductase | T26623 | SEA |
| P33527 | ABCC1 | Multidrug resistance-associated protein 1 | T11288 | SEA |
| P15692 | VEGFA | Vascular endothelial growth factor A | T20761 | SEA |
| P52789 | HK2 | Hexokinase type II | T96685 | SEA |
| P01112 | HRAS | Transforming protein p21/H-Ras-1 | T71081 | SEA |
| P60568 | IL2 | Interleukin-2 | T61698 | SEA |
| P30837 | ALDH1B1 | Acetaldehyde dehydrogenase | T99641 | SEA |
| P49763 | PGF | Placenta growth factor | T70792 | SEA |
| P14679 | TYR | Tyrosinase | T97035 | SEA |
| Q9NPH5 | NOX4 | NADPH oxidase 4 | T29741 | SEA |
| Q9GZQ4 | NMUR2 | Neuromedin-U receptor 2 | T04210 | SEA |
| P47989 | XDH | Xanthine dehydrogenase | T40954 | SEA |
| Q16678 | CYP1B1 | Cytochrome P450 1B1 | T92521 | SEA |
| P16152 | CBR1 | Carbonyl reductase [NADPH] 1 | T70518 | SEA |
| P09382 | LGALS1 | Galectin-1 | T09544 | SEA |
| Q13332 | PTPRS | Receptor-type tyrosine-protein phosphatase S | T10147 | SEA |
| Q9NZ08 | ERAP1 | Endoplasmic reticulum aminopeptidase 1 | T72849 | SEA |
| O43826 | SLC37A4 | Glucose-6-phosphate translocase | T47306 | SEA |
| Q99417 | MYCBP | MYCBP messenger RNA | T37298 | SEA |
| P16220 | CREB1 | Cyclic AMP-responsive element-binding protein | T92098 | SEA |
| P30837 | ALDH1B1 | Acetaldehyde dehydrogenase | T99641 | SEA |
| Q9UK17 | KCND3 | Voltage-gated potassium channel Kv4.3 | T74500 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T86462 | DI0026 | Amyloidosis | [ICD-11: 5D00] | P02766 | TTR |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T26623 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P15121 | AKR1B1 |
| T26623 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P15121 | AKR1B1 |
| T11288 | DI0167 | Gout | [ICD-11: FA25] | P33527 | ABCC1 |
| T20761 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P15692 | VEGFA |
| T20761 | DI0365 | Retinopathy | [ICD-11: 9B71] | P15692 | VEGFA |
| T20761 | DI0430 | Vascular system developmental anomaly | [ICD-11: LA90] | P15692 | VEGFA |
| T96685 | DI0133 | Epidermal dysplasias | [ICD-11: EK90] | P52789 | HK2 |
| T61698 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P60568 | IL2 |
| T61698 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P60568 | IL2 |
| T99641 | DI0396 | Substance abuse | [ICD-11: 6C40] | P30837 | ALDH1B1 |
| T70792 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P49763 | PGF |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T29741 | DI0146 | Fibrosis | [ICD-11: GA14-GC01] | Q9NPH5 | NOX4 |
| T40954 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | P47989 | XDH |
| T40954 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P47989 | XDH |
| T70518 | DI0037 | Asthma | [ICD-11: CA23] | P16152 | CBR1 |
| T10147 | DI0057 | Bone paget disease | [ICD-11: FB85] | Q13332 | PTPRS |
| T37298 | DI0235 | Liver cancer | [ICD-11: 2C12] | Q99417 | MYCBP |
| T99641 | DI0396 | Substance abuse | [ICD-11: 6C40] | P30837 | ALDH1B1 |
| T74500 | DI0004 | Acidosis | [ICD-11: 5C73] | Q9UK17 | KCND3 |